A new poll has placed Reform UK leader Nigel Farage ahead of Keir Starmer as the public’s preferred choice for prime minister - the first time he has led in such polling. The survey, conducted from 10 to 13 October among 1,141 people, found 33% favoured Farage and 30% Starmer, while 29% were undecided. Ipsos’s Keiran Pedley said the result marks 'an intriguing shift' in the political landscape, with growing public confidence in Reform’s economic and immigration policies - issues Britons see as most important. Separate YouGov research also shows Labour’s support slipping to a record low of 17%, tied with the Conservatives, while Reform leads with 27%. The Greens have 16% and the Liberal Democrats 15%. Farage’s growing appeal, fuelled by dissatisfaction with both major parties, signals rising volatility in UK politics. Pressure is mounting pressure on Labour ahead of the autumn budget and next year’s local and national elections.

The Government has unveiled its new ‘Carbon Budget and Growth Delivery Plan’, reaffirming the UK’s commitment to achieving net zero emissions while boosting economic growth. Energy secretary Ed Miliband said the plan will accelerate renewable energy, remove fossil fuels from the power grid by 2030, and cut greenhouse gas emissions by 2037. After a High Court ruling that the previous strategy lacked evidence to meet legal climate targets, the new plan outlines measures to expand clean power, promote heat pumps, and improve access to electric vehicle charging, while avoiding a gas boiler ban. A companion ‘Methane Action Plan’ aims to curb emissions from this potent greenhouse gas. Environmental groups largely welcomed the renewed ambition, though campaigners urged stronger action on aviation and housing. Critics warned of high costs and delayed delivery. Miliband insisted the plan would bring cleaner air, warmer homes, and new green jobs - securing a sustainable, prosperous future for coming generations.

A major European study has found that offering routine prostate cancer screening to all men over 50 could save thousands of lives. The 23-year trial of 162,000 men across eight countries showed that regular prostate-specific antigen (PSA) blood tests reduced prostate cancer deaths by 13%, matching the life-saving impact of breast and bowel cancer screening. The findings strengthen calls for the UK to introduce a national prostate screening programme. Experts say earlier detection allows curative treatment before symptoms appear, though some warn of overdiagnosis and overtreatment of harmless tumours. Advances such as MRI scanning and precision surgery now reduce these risks. Prostate cancer is the UK’s most common cancer, causing more than 12,000 deaths a year. Health officials will review the results next month, and advocates say the evidence is now overwhelming. Campaigners urge government action to protect men’s health, noting that high-risk groups such as black men and those with family histories remain especially vulnerable.

A new survey by the Children’s Society reveals that over half of UK teenagers (56%) feel overwhelmed by expectations surrounding Christmas. The poll of nearly 2,000 young people aged 13 to 16 found that school deadlines, social media pressure, and family expectations are major stress factors. Almost a third cited looming exams, while 28% said constant exposure to 'perfect' online images of gifts, parties, and families made them feel inadequate. One in five admitted finding it hardest to 'look happy' when they didn’t feel it. Although some teens found social media uplifting, many said it made them feel worse, especially when reminded of holidays or lifestyles they couldn’t afford. Many wanted less pressure to perform and more understanding from adults. Mark Russell, CEO of the Children’s Society, said many young people feel crushed by constant demands, urging greater access to early mental health and wellbeing support. The charity’s mission is to help teenagers find peace, perspective, and the true joy of Christmas.

UK inflation held steady at 3.8% in September, slightly below expectations and suggesting the current spike may have peaked. Economists predict a gradual decline through spring as last year’s regulated price rises drop out of the index, with inflation potentially nearing the 2% target by late next year. Although still nearly double the Bank of England’s goal, stability in food and energy prices has reduced the risk of inflationary “doom loops” where rising wages and prices fuel each other. The improved outlook has prompted renewed speculation about interest rate cuts — possibly four over the next year, bringing rates down to 3%. Market confidence has lifted, with government borrowing costs falling to their lowest levels in months. Chancellor Rachel Reeves, who recently pitched Britain as “the best place to invest,” now has slightly more room to manoeuvre ahead of a challenging Budget. However, analysts warn that new tax measures or global shocks could quickly reverse these gains.

The Metropolitan Police have begun testing an advanced “Drone as First Responder” system, deploying remotely operated aircraft across London to assist officers in real-time emergencies. The drones can reach incident scenes within two minutes, streaming live footage back to control rooms to support decision-making, locate suspects, or find missing people. The pilot scheme, launched in Islington, will extend to the West End and Hyde Park by December. Assistant Commissioner Laurence Taylor said the technology offers a faster, quieter, and more environmentally friendly alternative to helicopters, providing “a vital new tool to tackle crime in the capital.” The drones are stored in weatherproof rooftop pods, ready to launch automatically when activated by control room staff. Their live imagery helps determine how many officers or resources are needed at the scene and can guide rapid arrests. Similar trials are underway in several UK police forces, with national chiefs calling it a major step forward in precision policing and public safety.

A migrant who was deported to France under the UK’s new “one in, one out” return scheme has crossed the Channel again and re-entered Britain. The Iranian man, removed on 19 September, reportedly fled back four days ago, saying he feared for his life in France after being abused and threatened by smuggling gangs. He told *The Guardian* that he was treated “like a worthless object,” forced to work, and threatened with a gun. Human rights advocates say his case exposes serious flaws in the rushed removals process, claiming some deported individuals received inadequate legal advice and faced mistreatment. The Home Office insists it will not tolerate “abuse of our borders” and that anyone re-entering illegally will again be removed. The UK-France treaty aims to deter Channel crossings by returning migrants whose asylum claims are rejected while accepting others with legitimate protection needs. Despite this, crossings continue to rise, now exceeding 36,800 so far this year.

The government’s grooming gang inquiry has plunged into crisis after Jim Gamble, its expected chair, withdrew, calling it a “toxic political football.” His resignation followed that of four survivor-panel members, who said they would only return if safeguarding minister Jess Phillips resigned. Victims accused Phillips of lying to MPs and publicly discrediting survivors to “save her own skin.” Fiona Goddard, a grooming gang survivor, produced evidence contradicting Phillips’s claims about the inquiry’s scope. Senior Conservatives and some Labour MPs have joined calls for her resignation, while children’s minister Josh MacAlister defended her record as a “lifelong advocate for victims.” In an attempt to stabilise the process, Sir Keir Starmer appointed Baroness Casey to advise on rebuilding trust and appointing a new chair, insisting the inquiry “will never be watered down.” Jim Gamble and Annie Hudson both withdrew from the process to be appointed as Chair of the inquiry. Gamble said he withdrew because the process had become politically poisoned, overshadowing the voices of victims the inquiry was meant to serve. Survivors now await leadership they can trust. See

Kingdom Bank, a Christian financial institution dedicated to serving churches and believers, has been listed among the UK’s 500 fastest-growing companies. Ranked 380th overall, the bank attributes its success to God’s provision and the faithfulness of Christians who save with them. Their deposits enable the bank to provide mortgages for evangelical churches seeking permanent buildings for worship and community outreach. Chief Executive Paul Houghton said the recognition reflects “the increasing and urgent demand from churches across the UK” and the vital role of faith-based finance in supporting Gospel ministry. Kingdom Bank was also placed 302nd for profit and 193rd for profit margin, with all surpluses reinvested to expand lending capacity to churches, charities, and ministry workers. Looking ahead, the bank’s continued growth depends on more Christians choosing to save with them. “Every pound saved helps more churches secure a permanent home for mission,” said Houghton, reaffirming Kingdom Bank’s vision to strengthen the Church’s long-term witness across the UK.

Groundbreaking research has revealed that the diabetes and weight-loss drug semaglutide—sold as Ozempic and Wegovy—can significantly reduce the risk of heart attacks and strokes, even for patients who do not lose much weight. The global trial, involving over 17,000 participants across 41 countries, found that semaglutide cut major cardiovascular events by around 14–20%. Researchers discovered that shrinking waist size accounted for about one-third of the benefit, but two-thirds remained unexplained, suggesting the drug directly protects heart health rather than simply improving it through weight loss. Professor John Deanfield of University College London said the results “reframe what we think this medication is doing,” calling it a “disease-modifying therapy for ageing.” Experts describe the findings as “profound,” urging that the drug’s use not be limited to severely obese patients. However, they also cautioned that side effects must be carefully monitored as its use expands. The breakthrough could mark the most significant advance in cardiovascular medicine since statins.